IDEAYA Biosciences Announces Participation in Upcoming December 2024 Investor Relations Events

SOUTH SAN FRANCISCO, Calif., Dec. 2, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations events.Citi's 2024 Global Healthcare ConferenceTuesday, December 3rd, 2024 at 8:00 AM ET Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Yigal D. Nochomovitz, Ph.D., Director, SMid Cap Biotech Analyst7th Annual ...